Patent Application: Dichrostachys glomerata Health Benefits
Summary
The USPTO has published a patent application (US20260083791A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety, food cravings, and stress, and improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.
What changed
This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions utilizing Dichrostachys glomerata for purported health and wellness benefits in mammals, such as reducing anxiety, food cravings, and stress, while improving mood, physical and mental health, energy, and happiness. The application specifies oral dosage forms like pills, capsules, liquids, lozenges, or tablets.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on companies. However, it indicates potential future developments in therapeutic products derived from this plant. Companies in the pharmaceutical and biotechnology sectors may wish to monitor the progress of this application and related intellectual property developments in the area of natural product-based therapeutics.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL
Application US20260083791A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari
Abstract
Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing anxiety in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61P 25/22
Filing Date
2024-09-25
Application No.
18896177
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.